GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » 5-Year Yield-on-Cost %

Exact Therapeutics AS (OSL:EXTX) 5-Year Yield-on-Cost % : 0.00 (As of May. 25, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Exact Therapeutics AS 5-Year Yield-on-Cost %?

Exact Therapeutics AS's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for Exact Therapeutics AS's 5-Year Yield-on-Cost % or its related term are showing as below:



OSL:EXTX's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.8
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Exact Therapeutics AS's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Exact Therapeutics AS's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Exact Therapeutics AS's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exact Therapeutics AS's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Exact Therapeutics AS's 5-Year Yield-on-Cost % falls into.



Exact Therapeutics AS 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Exact Therapeutics AS is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Exact Therapeutics AS  (OSL:EXTX) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Exact Therapeutics AS 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Exact Therapeutics AS's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Exact Therapeutics AS (OSL:EXTX) Business Description

Traded in Other Exchanges
N/A
Address
Ostre Aker vei 19, Oslo, NOR, 0581
Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing a technology platform for therapeutic enhancement - Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Exact Therapeutics AS (OSL:EXTX) Headlines

No Headlines